RECURSION PHARMACEUTICALS, INC. (RXRX) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

Loading RXRX…

RECURSION PHARMACEUTICALS, INC. (RXRX) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

SEC filing

RECURSION PHARMACEUTICALS, INC.

RXRX · CIK 1601830

4 · Oct 7, 2026 · Director Borgeson Blake sold 50K Class A Common Stock at $4.84/unit ($242K)

4

Director Borgeson Blake sold 50K Class A Common Stock at $4.84/unit ($242K)

Filed: Oct 7, 2026
Period: Oct 6, 2026
Accession: 0001601830-26-000120
Filer: RECURSION PHARMACEUTICALS, INC.

View on SEC.gov All SEC filings

Filing document

FORM 4

xslF345X06/wk-form4_1791410921.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4FORM 4wk-form4_1791410921.xml
Open SEC.gov